CAM
VIR icon

Cresset Asset Management’s Vir Biotechnology VIR Stock Holding History

Cresset Asset Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-17,350
Closed -$112K – 1790
2025
Q1 		$112K Sell
17,350
-7,859
-31% -$69.9K ﹤0.01% 1606
2024
Q4 		$185K Sell
25,209
-5,681
-18% -$44.8K ﹤0.01% 1578
2024
Q3 		$231K Sell
30,890
-7,718
-20% -$67K ﹤0.01% 1926
2024
Q2 		$344K Sell
38,608
-4,438
-10% -$42.6K ﹤0.01% 1644
2024
Q1 		$436K Sell
43,046
-83,869
-66% -$854K ﹤0.01% 1404
2023
Q4 		$1.28M Buy
126,915
+37,741
+42% +$345K 0.01% 789
2023
Q3 		$836K Buy
89,174
+22,937
+35% +$327K ﹤0.01% 940
2023
Q2 		$1.62M Buy
+66,237
New +$1.66M ﹤0.01% 715

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return